Clinical Trial Update: Bioequivalence of Adapalene Topical Gel in Patients With Acne Vulgaris [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study of Adapalene Topical Gel for Acne Vulgaris has been completed, sponsored by Teva Pharmaceuticals USA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Adapalene Topical Gel (adapalene)

Snippet

Sponsor: Teva Pharmaceuticals USA | Conditions: Acne Vulgaris | Phase 1 | Status: COMPLETED